ImageneBio, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +26.0% | -28.2% | -58.0% | -2.2% | -1.1% | -2.2% | +0.0% | -331.0% | – | -51.0% | +1.1% | – | |
| – | -12.2% | +14.0% | -36.1% | -20.5% | -1.9% | -9.4% | -49.3% | +2,952.0% | -99.6% | +1,617.6% | +4.0% | – | |
| – | – | – | – | – | – | -312.8% | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -36.1% | -339.2% | – | +141.3% | -95.1% | +1,613.2% | +214.5% | -249.6% | -96.3% | -67.7% | -21.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.8% | – | – | – | – | -99.6% | +48,111.1% | +940.7% | -100.0% | – | – | – | |
| – | -102.7% | – | – | – | -1,223.4% | – | – | +108.4% | -119.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.